Additionally, the inhibitory epithelial-to-mesenchymal transition (EMT) effect of FBP1 has been identified in gastric cancer, where loss of FBP1 expression supported cancer cell growth through increased glycolysis [72]. This evidence concerns the gene FBP1 and cancer.